Journal of Oncology Research and Treatment
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Commentary   
  • J Oncol Res Treat,
  • DOI: 10.4172/aot.1000163

HIF2-Plk1, An Oncogenic Pathway in Clear Cell Renal Cell Carcinoma

Maeva Dufies1,2* and Gilles Pagès1,2,3
1Centre Scientifique de Monaco, Biomedical Department, 8 quai Antoine Premier, 98000 Monaco, Principality of Monaco, Monaco
2LIA ROPSE, Laboratoire International Associé Université Côte d’Azur-Centre Scientifique de Monaco, Monaco
3University Côte d’Azur, Institute for Research on Cancer and Aging of Nice(IRCAN), CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, 06189 Nice, France
*Corresponding Author : Maeva Dufies, Centre Scientifique de Monaco, Biomedical Department, 8 quai Antoine Premier, 98000 Monaco, Principality of Monaco, LIA ROPSE, Laboratoire International Associé Université Côte d’Azur-Centre Scientifique de Monaco, Monaco, Email: maeva.dufies@gmail.com

Received Date: May 10, 2021 / Accepted Date: May 24, 2021 / Published Date: May 31, 2021

Citation: Dufies M and Pages G (2021) Hif2-Plk1, An Oncogenic Pathway in Clear Cell Renal Cell Carcinoma. J Oncol Res Treat. 6:163. Doi: 10.4172/aot.1000163

Copyright: © 2021 Dufies M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top